Practical points on therapeutics and diagnostics

Pearls from members

“Therapeutic and Diagnostic Pearls” (S068)
Tuesday, 10:30 a.m.–12:30 p.m.
Room 6B

Jeremy Adam Schneider, MD
Assistant clinical professor, department of dermatology, University of California, San Diego, and VA San Diego Healthcare System

“As the care of hospitalized patients becomes further subspecialized, dermatologists have an increasingly important role in the management of inpatients, particularly those suffering from severe cutaneous adverse reactions, such as Stevens-Johnson syndrome/toxic epidermal necrolysis and drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms. Early recognition and evidence-based management of these reactions can have a profound impact for these patients, and education of our non-dermatologist colleagues may, similarly, help to reduce the morbidity and mortality associated with these conditions. The consultative dermatologist must take a pragmatic approach, with a focus on our field’s evolving understanding of pathogenesis and therapeutic approaches to these life-threatening drug reactions.”

Taraneh Paravar, MD
Assistant professor, department of dermatology, University of California, San Diego

“Dermatologists have a critical role in the care and management of patients with connective tissue diseases of the skin. The assessment of the skin may assist in the initial diagnosis of a patient, such as in systemic lupus erythematosus, or may allow for the identification of features that are markers of internal organ involvement, such as inpatients with amyopathic dermatomyositis at risk for rapidly progressive interstitial lung disease. For these reasons, it is important for dermatologists to have a role in the co-management and care of patients with connective tissue disease of the skin, and in cases when the skin is the primary area of involvement, be the primary managing physician.”


Return to index